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Abstract Nutritional inﬂuences on cardiovascular dis-
ease operate throughout life. Studies in both experimental
animals and humans have suggested that changes in the
peri- and early post-natal nutrition can affect the devel-
opment of the various components of the metabolic syn-
drome in adult life. This has lead to the hypothesis that n-3
fatty acid supplementation in pregnancy may have a ben-
eﬁcial effect on lipid proﬁle in the offspring. The aim of the
present study was to investigate the effect of supplemen-
tation with n-3 fatty acids during the third trimester of
pregnancy on lipids and lipoproteins in the 19-year-old
offspring. The study was based on the follow-up of a
randomized controlled trial from 1990 where 533 pregnant
women were randomized to ﬁsh oil (n = 266), olive oil
(n = 136) or no oil (n = 131). In 2009, the offspring were
invited to a physical examination including blood sam-
pling. A total of 243 of the offspring participated. Lipid
values did not differ between the ﬁsh oil and olive oil
groups. The relative adjusted difference (95% conﬁdence
intervals) in lipid concentrations was -3% (-11; 7) for
LDL cholesterol, 3% (-3; 10) for HDL cholesterol, -1%
(-6; 5) for total cholesterol,-4% (-16; 10) for TAG
concentrations, 2%(-2; 7) for apolipoprotein A1, -1%
(-9; 7) for apolipoprotein B and 3% (-7; 15) in relative
abundance of small dense LDL. In conclusion, there was
no effect of ﬁsh oil supplementation during the third tri-
mester of pregnancy on offspring plasma lipids and lipo-
proteins in adolescence.
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Abbreviations
Apo-A Apolipoprotein A1
Apo-B Apolipoprotein B100
CVD Cardiovascular disease
PUFA Polyunsaturated fatty acids
RCT Randomized controlled trial
sdLDL Small dense LDL particles
TAG Triacyglycerols
Introduction
Development of cardiovascular disease (CVD) is a life-
long process [1, 2]. This has led to the hypothesis that
exposures early in life may play a role for the later
development of CVD. High blood pressure, obesity,
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DOI 10.1007/s11745-011-3606-5atherosclerosis and diabetes develop over time, and risk
factors may be detectable early in life [2–6]. Prevention
may therefore be possible by targeting factors leading to
CVD early in life.
A lipid proﬁle, with high plasma levels of LDL-cho-
lesterol, triacylglycerols (TAG) and apolipoprotein B100
(Apo-B) and a low concentration of HDL-cholesterol and
apolipoprotein A1 (Apo-A), increase the risk of athero-
sclerosis and CVD [7, 8]. Also, plasma LDL particles are
comprised of different sub-fractions, differing in chemical
composition, size and density, and studies have suggested
that particularly the fraction of small dense LDL particles
(sdLDL) is associated with CVD [9, 10]. sdLDL is strongly
correlated with plasma TAG, and generally the strong
correlation between the different lipid fractions makes it
difﬁcult to identify the contribution of the separate frac-
tions to the risk of CVD [7, 8, 11].
Fish consumption and supplementation with n-3 poly-
unsaturated fatty acids (PUFA) in adulthood have been
associated with slightly increased levels of HDL choles-
terol, lower TAG concentration, and both a lower relative
abundance and particle number of sdLDL [12, 13]. Also,
ﬁsh oil supplementation during infancy has been found to
be associated with a decrease in plasma TAG concen-
tration and an increase in the concentration of plasma
LDL and total cholesterol [14, 15]. It is, however, not
known whether these effects of n-3 PUFA found early in
life can track and program the future lipid proﬁle of the
child [16].
Breast feeding has also been shown to increase choles-
terol concentration in infancy [17]. These short-term
effects of breast feeding are, translated into a long-term
decrease in total cholesterol in adulthood [17]. This effect
is thought to be caused by the relatively high cholesterol
concentration of breast milk, leading to a decrease in the
endogenous production of cholesterol. However, breast
milk also contains high concentrations of n-3 PUFA, which
could potentially inﬂuence lipid metabolism. To our
knowledge, only one study has looked into the long-term
effect of ﬁsh oil supplementation during early life on the
lipid proﬁle in adulthood [18]. In this study, no association
between increased dietary intake of n-3 PUFA during the
ﬁrst 5 years of life and lipid proﬁle at the age of 8 years,
was found.
We investigated the hypothesis that supplementation
with long chain marine n-3 PUFA during fetal life has an
impact on the plasma lipid proﬁle in adolescence. This
was done by studying offspring from a randomized con-
trolled trial conducted in 1990, where pregnant women
were randomized to ﬁsh oil, olive oil or no oil [19]. No
association between ﬁsh oil supplementation during
pregnancy and blood lipid proﬁle in the offspring was
found.
Methods
The aim of the original study was to investigate the effect
of ﬁsh oil supplementation on gestational length. The
recruitment and randomization of the original study pop-
ulation has previously been described in detail [19].
Brieﬂy, 533 women in gestational week 30 who attended
the Midwife Centre in Aarhus, Denmark, were randomized
to four 1 g ﬁsh oil capsules (FO) (Pikasol: 32% eicosa-
pentaenoic acid and 23% docosahexaenoic acid, corre-
sponding to approximately 2.7 g marine n-3 PUFA) per
day (n = 266), four similar capsules with olive oil (OO)
(n = 136) or no capsules (NO) (n = 131) in 1990. The
women receiving oil were blinded for study interventions,
and the capsules and boxes looked identical. The 533
enrolled and randomized women represented 61% of eli-
gible women.
The offspring from the abovementioned randomized
controlled trial constituted the study population in the
present study. At the time of the study, the offspring were
aged between 18 and 19 years. A total of 517 (97%)
mother and child pairs were alive and living in Denmark.
All the mothers were contacted by mail and they invited
their children to complete a self-administered web-based
questionnaire concerning anthropometric measures, health
and lifestyle. The offspring were also asked whether they
wanted to receive an invitation for a physical examination.
Those accepting and those who did not respond were all
invited to the physical examination. A total of 382 ﬁlled
out the questionnaire and 243 participated in the clinical
examination (Fig. 1).
At the physical examination, a fasting venous blood
sample was drawn, centrifuged and frozen at -80 C.
Serum TAG and cholesterol fractions (Total, LDL,
HDL) were measured according to standard methods on a
Modular P from Roche Diagnostics, Basel, Switzerland.
Apo-B was measured using antibody from DAKO, Glost-
rup, Denmark, on an Advia 1650 from Bayer Diagnostics,
NY, USA. Interserial variation was 5.5%. Apo-A was
measured using antibody from DAKO, Glostrup, Denmark,
on an Advia 1650 from Bayer Diagnostics, NY, USA.
Interserial variation was 5%.
For the sdLDL analysis, blood, anticoagulated with
K3-EDTA1.6 mg/ml,wascentrifugedandplasmastoreduntil
analysis. Plasma, adjusted to 1.067 g/L with 60% iodixanol
from Optiprep, Axis-Schield PoC As, Oslo, Norway, was
prestained with Coomassie blue, under-layered beneath 9%
iodixanol and subjected to ultracentrifugation (2 h,
65.000 rpm 16 C (341.000 g) in a near vertical rotor
(Beckmann NVT65). A digital photograph of LDL sub-
class proﬁles was analyzed using Total Lab 1D gel-scan
software (Pharmacis, UK). LDL subclass phenotypes A, B
and I (Intermediate) were characterized according to the
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(sd-LDL) as follows: A: AUC B\40%, I: AUC B 40-50%,
B: AUC B[50%. The method has been described in detail
previously [20].
Covariates
Information on the mother was collected from the inter-
view and questionnaire during pregnancy. The pregnant
women ﬁlled out a simple food frequency questionnaire in
order to assess their baseline ﬁsh consumption, and three
categories were deﬁned according to ﬁsh consumption.
Characteristics of the children were collected from the
questionnaire at 18–19 years of age. For this reason, we
only had information regarding covariates for the non-
participating children who ﬁlled out the questionnaire.
Information on sex, gestational age and birth weight were
collected from medical records.
This study was conducted according to the guidelines
laid down in the declaration of Helsinki and all procedures
involving human subjects were approved by the local
ethics committee (case no.: M-A ˚A 20060182) and the
Assessed for eligibility
(n=868)
Excluded* (n= 335 )
(not meeting inclusion criteria,
refused to participate or other
reasons)
Included in analyses
(n= 72 )
Lost to follow-up
n= 2 due to death or
residence outside Denmark
of child or mother
n=18 refuse any
participation
n=23 filled out questionnaire
but refused clinical
examination
n=4 not able to participate
in clinical examination
n= 17 no response
A l l o c a t e dt o' o l i v eo i l '
(n= 136 )
Loss to follow-up:
n=2 not identified in
registries
n=4 due to death or
residence outside Denmark
of child or mother
n=34 refused any
participation
n=64 filled out
questionnaire but refused
clinical examination
n=6 not able to participate
in clinical examination
n=48 no response
Allocated to 'fish oil
(n= 266)
Included in analyses
(n= 108 )
Allocation
Analysis
Follow-Up
Enrollment
Randomization
Allocated to 'no oil'
(n= 131)
Loss to follow-up
n=1 due to not being
identified in registries
n= 7 due to death or
residence outside Denmark
of child or mother
n=18 refuse any
participation
n=23 filled out
questionnaire but refused
clinical examination
n=2 not able to participate
in clinical examination
n= 17 no response
Included in analyses
(n= 63 )
Fig. 1 Flow chart. Nineteen years follow-up of offspring from a randomized controlled trial with ﬁsh oil supplementation in pregnancy.
Reprinted with permission from Lancet [19] has previously been published [28] and is reprinted with permission from Am J Clin Nutr
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123Danish Data Protection Agency (journal no.: 2006-41-
6257). Written informed consent was obtained from all
subjects.
Statistics
The OO group was used as the reference in the study for
the following reasons: (1) the original study showed that
blinding worked well in the OO group, indicating that this
group was unlikely to have increased their ﬁsh consump-
tion during the trial period. (2) It seems reasonable to
assume that OO in the supplemented amounts was inert.
The results from the NO group are, however, also pre-
sented in the tables.
The distribution of biochemical variables was generally
skewed, and therefore log transformation was applied to
normalize the distribution. Geometric means and inter-
quartile ranges are presented.
Chi-square tests and Student’s t-tests were used to
compare categorical and normally distributed continuous
covariates, respectively, between participants and non-
participants as well as between the FO and OO groups with
two-sided p-values \0.05 considered statistically signiﬁ-
cant. For covariates that were not normally distributed or
did not have the same variance in the two groups, Wilco-
xon rank sum test was used to test for differences between
groups.
Differential programming effects may be found in boys
and girls, and therefore the analyses used to estimate the
association between ﬁsh oil and later lipid proﬁle were
initially stratiﬁed by sex, using ANOVA. Since the asso-
ciations were similar in males and females, multiple linear
regression modeling adjusting for sex was used to estimate
the association. Also, since supplementation with ﬁsh oil
would be expected to have the largest effect among preg-
nant women with a low baseline ﬁsh intake, the multiple
linear regression analyses were also done by only including
participants of mothers with a low baseline ﬁsh intake
(n = 46). All associations are reported as percentage dif-
ference, since they were all analyzed on the log-scale.
In addition to analyzing the effect on the relative abun-
dance of sdLDL (% of total number of LDL particles) using
multiple linear regression, also the effect on the prevalence
of LDL subclass B (prevalence of sdLDL[50%) was
estimated by logistic regression, adjusting for sex.
Results
Participants
Characteristics of those participating in the clinical exam-
ination and the non-participants are given in Table 1. The
participants differed from the non-participants with regard
to the mother’s age during pregnancy, sex and birth weight.
Also, the participation rates differed between randomiza-
tion groups, being lower in the FO group (41%) compared
with the OO group (53%). A number of women in the FO
group experienced side effects such as gastric reﬂux during
supplementation. When invited to the follow-up, a few
mothers reported that they did not think it was relevant for
their child to participate since they did not comply with the
original study protocol, due to side effects. The women
were contacted in writing and the importance of partici-
pating was explained, irrespective of compliance. How-
ever, among those participating in the clinical examination
from the FO group, 1.9% of the mothers took less than 75%
of the daily dosage as opposed to 8.6% among non-par-
ticipants. In the OO group, 2.8% of those participating in
the follow-up and 3.2% of non-participants took less than
75% of the daily dosage. There was no information on
compliance for 14.6 and 20.9% of the women receiving FO
and OO, respectively.
A description of the participants in the three randomi-
zation groups is given in Table 2. The three groups were
similar with respect to most covariates. The only difference
reaching statistical signiﬁcance was the smoking status in
the offspring, with smoking being more prevalent among
participants from the OO group compared to the other two
groups.
The participants in the study were generally healthy.
The median (interquartile range) was 4.0 (3.6; 4.7) mmol/l
for total cholesterol, 1.3 (1.1; 1.6) mmol/l for HDL cho-
lesterol, 2.3 (1.8; 2.7) mmol/L for LDL cholesterol and 0.9
(0.6; 1.2) mmol/L for TAG. In light of the recommended
lipid levels in healthy subjects from international guide-
lines a total of 14% had a total cholesterol concentration
above 5 mmol/L, 9% an HDL cholesterol concentration
less than 1 mmol/L, 18% a LDL cholesterol concentration
above3 mmol/Landonly3%hadaTAGconcentrationabove
2m m o l / L .
Fish oil supplementation during pregnancy was not
associated with cholesterol concentrations (total choles-
terol, LDL, and HDL), TAG concentration or Apo-A1 and
Apo-B in the offspring (Table 3). Also, no association was
found with relative abundance of sdLDL. However, when
restricting the analyses to participants of mothers with a
low baseline ﬁsh intake, there was a tendency towards a
healthier lipid and lipoprotein proﬁle in participants from
the FO group compared with the OO group (Table 4).
Particularly, TAG, Apo-B and LDL cholesterol tended to
be lower in the FO group, but none of the differences were
statistically signiﬁcant.
The distribution of LDL subclass phenotypes A, B and I
(Intermediate) in the three randomization groups, stratiﬁed
by sex, is shown in Fig. 2. There was a tendency towards a
1094 Lipids (2011) 46:1091–1099
123lower prevalence of phenotype B and larger prevalence of
phenotype I in the FO and NO groups compared to the OO
group. However, the difference did not reach statistical
signiﬁcance. Sex was signiﬁcantly associated with LDL
phenotype, with phenotype B being more prevalent among
males.
Discussion
We found no association between ﬁsh oil supplementation
during pregnancy and lipid and lipoprotein proﬁle in the
19-year-old offspring. The LDL phenotype in the FO
group tended to be healthier in comparison to the
Table 1 Characteristics of
participants and non-
participants from the follow-up
of a randomized controlled trial
with ﬁsh oil supplementation
during pregnancy
The table has previously been
published [28] and is reprinted
with the permission from Am J
Clin Nutr
OO olive oil, NO no oil, FO ﬁsh
oil
a Information collected from a
self-administered questionnaire
to the pregnant women in week
16 of gestation
b Presented as number of
participants; % in parentheses
c Chi-square test
d Presented as mean ± SD
e Student’s t test
f Presented as median, inter-
quartile range in parentheses
g Wilcoxon rank sum test
h Information collected from a
self-administered web-based
questionnaire to the offspring at
the age of 18–19. Sex and birth
weight collected from medical
records
i Deﬁned as regular exercise of
at least 20 min duration,
resulting in breathlessness
n Participants Non-participants p
Mother
a
Parity
b 517 0.82
c
0 145 (60) 168 (63)
1 76 (31) 79 (29)
[1 22 (9) 27 (10)
Age at giving birth
d 517 30 ± 42 9 ± 4 0.03
e
Smoking
b (yes) 516 67 (28) 93 (34) 0.11
c
Mother’s pre-pregnancy BMI
f (kg/m
2) 479 21 (20; 23) 21 (20; 23) 0.16
g
Fish intake
b 517 0.76
c
Low 46 (19) 59 (22)
Medium 141 (58) 155 (57)
High 56 (23) 60 (22)
Offspring
h (19 years)
Female
b 517 136 (56) 100 (37) \0.001
c
Smokers
b 370 0.68c
c
Current 39 (17) 25 (19)
Ex-smoker 13 (6) 6 (4)
Occasional smoker 49 (21) 22 (16)
Never smoker 134 (57) 82 (61)
Fish hot meal
b 366 0.09
c
Never 33 (14) 16 (12)
1–2 per month 108 (46) 49 (37)
3–4 per month 71 (31) 46 (35)
[5 per month 21 (9) 22 (17)
Fish cold meal
b 360 0.71
c
Never 45 (19) 30 (24)
1–2 per month 95 (41) 45 (36)
3–4 per month 44 (19) 25 (20)
[5 per month 50 (21) 26 (21)
Exercise
b,i 363 136 (59) 80 (60) 0.95
c
Parental overweight (yes)
Mother
b 366 39 (17) 28 (20) 0.51
c
Father
b 356 44 (19) 31 (24) 0.28
c
Mother or father
b 355 71 (32) 45 (35) 0.56
c
Self-reported BMI
d (kg/m
2) 382 22 ± 32 2 ± 3 0.85
e
Birth weight
d (g) 517 3595 ± 486 3485 ± 511 0.01
e
Gestational age
f (days) 517 284 (278; 290) 283 (277; 289) 0.20
g
Randomization code
b 517 0.04
c
OO 72 (30) 62 (23)
NO 63 (26) 60 (22)
FO 108 (44) 152 (56)
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123phenotype of the OO group, but the difference was not
statistically signiﬁcant. Finally, there were indications of a
healthier lipid proﬁle among offspring of mothers with a
low baseline ﬁsh intake in the FO group, but with only 46
participants in this group, the conﬁdence intervals were
wide and no statistically signiﬁcant association could be
demonstrated.
Loss to follow-up was present overall but signiﬁcantly
higher in the FO group compared to the OO group. This
could potentially have led to bias, assuming that a lower
participation rate was associated with an unhealthy lipid
proﬁle. Participation per se would not be expected to be
directly associated with the lipid proﬁle, since most of the
participants probably were unaware of their lipid levels, but
an unhealthy lipid proﬁle is often associated with a high
BMI, and participation could be negatively associated with
BMI. However, according to the questionnaire data
(Table 1), participation was not associated with BMI.
Hence, it is unlikely that the results were biased for BMI.
The larger loss to follow-up in the FO group may partly
be caused by differences in compliance. Compliance was
higher among participants in the FO group compared to the
non-participants. By primarily including participants with
high compliance in the analyses, this would strengthen a
possible association between FO supplementation and later
lipid proﬁle. Hence, this cannot explain the ﬁnding of no
association in the present study. However, those complying
with the study protocol might be different from those not
complying, and hence this could introduce some residual
confounding.
Participation was associated with exposure and may also
be associated with e.g. lifestyle factors which could
Table 2 Characteristics of
mothers and offspring in the
olive oil, no oil and ﬁsh oil
groups from the follow-up of a
randomized controlled trial with
ﬁsh oil supplementation during
pregnancy
The table has previously been
published [28] and is reprinted
with permission from Am J Clin
Nutr
OO olive oil, FO ﬁsh oil, NO no
oil
a Information collected from a
self-administered questionnaire
to the pregnant women in week
16 of gestation
b Presented as number of
participants, % in parentheses
c Chi-square test
d Presented as mean ± SD
e Student’s t test ﬁsh oil versus
olive oil
f Presented as median, inter-
quartile range in parentheses
g Wilcoxon rank sum test
h Information collected from a
self-administered web-based
questionnaire to the offspring at
the age of 18–19. Sex and birth
weight collected from medical
records
i Deﬁned as regular exercise of
at least 20 min duration,
resulting in breathlessness
OO (n = 72) FO (108) NO (n = 63) p
Mother
a
Parity
b 0.83
c
0 42 (58) 65 (60) 38 (60)
1 24 (33) 32 (30) 20 (32)
[1 6 (8) 11 (10) 5 (8)
Age at birth
d 30 ± 43 0 ± 53 0 ± 4 0.90
b
Smokers
b (yes) 18 (25) 28 (26) 21 (33) 0.89
c
Pre-pregnancy BMI
f (kg/m
2) 21 (19; 23) 21 (20; 22) 22 (20; 23) 0.58
d
Offspring
h
Female
b 35 (49) 62 (57) 39 (62) 0.25
c
Smokers
b 0.002
c
Current 19 (27) 13 (13) 7 (12)
Ex-smoker 6 (9) 1 (1) 6 (10)
Occasional smoker 10 (14) 27 (26) 12 (20)
Never smoker 35 (50) 63 (61) 36 (59)
Fish hot meal
b 0.80
c
Never 10 (14) 18 (17) 5 (9)
1–2 a month 29 (41) 47 (45) 32 (56)
3–5 a month 23 (32) 30 (29) 18 (32)
[5 a month 9 (13) 10 (10) 2 (4)
Fish cold meal
b 0.09
c
Never 19 (28) 15 (14) 11 (19)
1–2 a month 27 (40) 42 (39) 26 (44)
3–5 a month 8 (12) 22 (21) 14 (24)
[5 a month 5 (21) 16 (26) 4 (14)
Exercise
b,i (yes) 39 (55) 63 (64) 34 (58) 0.98
c
Parental overweight
Mother
b 14 (21) 12 (12) 13 (22) 0.13
c
Father
b 11 (16) 21 (20) 12 (21) 0.52
c
Mother or father
b 22 (32) 29 (29) 20 (34) 0.64
c
Birth weight
d (g) 3543 ± 489 3642 ± 489 3574 ± 476 0.19
e
Gestational age
f (days) 283 (277; 289) 284 (280; 291) 285 (277; 291) 0.09
g
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123inﬂuence lipid proﬁle. Hence, such factors might confound
the association between FO supplementation and the lipid
proﬁle. In the main analysis we only adjusted for sex.
Additional adjustment for offspring smoking and parental
overweight did not change estimates.
To our knowledge, no other study has investigated the
effect of supplementing with n-3 PUFA during pregnancy
on later lipid proﬁle. However, ﬁsh oil supplementation
during pregnancy has been shown not to affect the lipid
proﬁle of the umbilical cord blood speaking against fetal
life as the right time window for ﬁsh oil supplementation
[21]. In another study where term infants were randomized
to an intervention aimed at increasing dietary intake of n-3
PUFA and decreasing intake of n-6 PUFA from the time of
weaning until the age of 5 years, no association between
intervention and lipid proﬁle was found when the children
were followed-up at the age of 8 years [18]. The children
were, however, very young at follow-up and effects may
not be visible until considerably later in life.
Several studies indicate that the lipid proﬁle in adult-
hood can be inﬂuenced, ‘‘programmed’’, by early nutrition.
Hence, Barker et al. showed that a low abdominal cir-
cumference at birth was associated with higher concen-
trations of total cholesterol, LDL cholesterol and Apo-B in
adulthood [22]. The authors argued that this could be a
consequence of impaired liver growth during late gestation
due to malnutrition. Accordingly, a study from the Dutch
Hunger Winter showed that persons, who were exposed to
hunger during early gestation, displayed signiﬁcantly
higher LDL to HDL ratios, and a tendency towards lower
plasma concentrations of HDL and Apo-A1 and higher
concentrations of LDL and Apo-B compared to persons
born before or after the Dutch Hunger Winter [23]. These
results, however, contradict results from the Leningrad
Siege, where no association between hunger during fetal
life or infancy and any of the lipid parameters in adulthood
was found [24].
A large body of research on programming of future
lipid proﬁle has focused on the effects of breast feeding.
The short-term effect of breast feeding in infants is an
increase in total cholesterol [17]. However, this effect may
be reversed in adulthood, where breastfeeding has been
found to be associated with a lower total cholesterol
concentration [17]. Hence, a high total cholesterol con-
centration early in life may be protective later in life.
Table 3 Concentration of lipid parameters in the three randomization groups and difference in concentrations relative to the olive oil group
OO (n = 72) NO (n = 63) FO (n = 108)
Geometric mean
a Geometric mean
a Difference
b (%) Geometric mean
a Difference
b
(%)
HDL C (mmol/L) 1.3 (1.1; 1.6) 1.3 (1.1; 1.5) -2( -8; 5) 1.4 (1.1; 1.6) 3 (-3; 10)
LDL C (mmol/L) 2.3 (2.0; 2.8) 2.2 (1.8; 2.7) -6( -15; 5) 2.3 (1.8; 2.8) -3( -11; 7)
Total C (mmol/L) 4.1 (3.6; 4.8) 4.0 (3.6; 4.5) -4( -10; 3) 4.1 (3.5; 4.7) -1( -6; 5)
TAG (mmol/L) 0.9 (0.6; 1.1) 0.9 (0.6; 1.3) 3 (-12; 20) 0.9 (0.7; 1.2) -4( -16; 10)
Apo-A1 (g/L) 1.4 (1.2; 1.5) 1.4 (1.2; 1.6) -2( -7; 3) 1.4 (1.2; 1.7) 2 (-2; 7)
Apo-B (g/L) 0.8 (0.7; 0.9) 0.7 (0.6; 0.9) -5( -13; 4) 0.8 (0.6; 0.9) -1( -9; 7)
sdLDL
c (%) 36.8 (30.2; 48.5) 33.8 (27.8; 43.5) -6( -16; 6) 37.4 (29.2; 43.9) 3 (-7; 15)
No statistically signiﬁcant difference was found for any of the lipid or lipoprotein fractions
OO olive oil, NO no oil, FO ﬁsh oil, HDL C high-density lipoprotein cholesterol, LDL C low-density lipoprotein cholesterol, Total C total
cholesterol, TAG triglycerides, Apo apolipoprotein, sdLDL small dense low-density lipoprotein
a Geometric mean, interquartile range in parentheses
b Difference (in %) relative to olive oil, adjusted for sex, 95% conﬁdence interval in parentheses
c n = 106 in FO group
Fig. 2 Distribution of LDL subclass phenotypes A, B and I (Interme-
diate)inthethreerandomizationgroups,stratiﬁedbysex.PhenotypesA,
B and I were characterized as follows: A: sdLDL\40% of LDL, I:
sdLDL 40-50% of LDL particles, B: sdLDL[50% of LDL particles.
There was no statistically signiﬁcant difference in the prevalence of
phenotype B between groups
Lipids (2011) 46:1091–1099 1097
123Also, a study where pre-term infants were randomized to
banked breast milk or formulae showed that those
receiving banked breast milk had a lower LDL to HDL
ratio in adolescence [25]. The mechanism behind the
effects of breast-feeding or breast milk on later lipid
proﬁle is unknown but may be associated with a lower
total energy intake [26] or the higher cholesterol con-
centration of breast milk compared to infant formulae. The
higher cholesterol concentration during early life could
potentially suppress endogenous cholesterol production
and hence lead to a lower cholesterol concentration later
in life [27]. However, breast milk is also high in n-3
PUFA. The short-term effect of supplementing infants
with ﬁsh oil on serum cholesterol is similar to that of
breast feeding [14, 17]. If the effect of breast feeding on
later lipid proﬁle is operating through increased choles-
terol levels in infancy by inducing decreased endogenous
cholesterol production, this could also be the case for ﬁsh
oil supplementation. Most of the women in the present
study had a medium to high baseline ﬁsh consumption
during pregnancy, and it is possible that this attenuated the
effect of ﬁsh oil supplementation. Thus, among the off-
spring of mothers with a low baseline ﬁsh intake, there
were indications of a beneﬁcial association between ﬁsh
oil supplementation and later lipid proﬁle. However, as
mentioned previously this sub-group analysis contain very
few numbers, making it difﬁcult to draw any conclusions.
Hence, further studies are needed to conﬁrm this poten-
tially important observation.
Finally, it should be had in mind that very few indi-
viduals in early adulthood have an unhealthy lipid proﬁle.
Potential beneﬁts of early supplementation with n-3 PUFA
on later lipid proﬁle might therefore not be detectable until
considerably later in life, and it will be important to follow-
up the offspring at later ages.
Conclusion
We found no association between ﬁsh oil supplementation
during third trimester of pregnancy and offspring plasma
lipid and lipoprotein proﬁle in adolescence.
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Table 4 Concentration of lipid parameters in the three randomization groups and difference in concentrations relative to the olive oil group
OO (n = 13) NO (n = 9) FO (n = 24)
Geometric mean
a Geometric mean
a Difference
b (%) Geometric mean
a Difference
b
(%)
HDL C (mmol/L) 1.4 (1.2; 1.6) 1.2 (1.1; 1.2) -11 (-26; 7) 1.4 (1.3; 1.7) 6 (-8; 22)
LDL C (mmol/L) 2.6 (2.3; 3.1) 2.5 (1.9; 3.0) -3( -24; 24) 2.2 (1.7; 2.6) -13 (-29; 5)
Total C (mmol/L) 4.5 (4.2; 5.2) 4.2 (3.7; 4.5) -6( -20; 10) 4.1 (3.5; 4.7) -8( -19; 4)
TAG (mmol/L) 1.1 (0.8; 1.3) 0.8 (0.7; 0.9) -21 (-47; 17) 0.8 (0.6; 1.25) -22 (-43; 6)
Apo-A1 (g/L) 1.5 (1.3; 1.6) 1.3 (1.1; 1.3) -11 (-22; 1) 1.5 (1.3; 1.7) 3 (-7; 14)
Apo-B (g/L) 0.8 (0.7; 1.0) 0.8 (0.6; 0.9) -3( -23; 21) 0.7 (0.6; 0.88) -11 (-26; 6)
sdLDL (%) 35.1 (29.7; 40.2) 32.4 (26.7; 36.4) -9( -31; 20) 38.4 (31.4; 42.8) 8 (-13; 34)
Analyses restricted to offspring of mothers with low baseline ﬁsh intake during pregnancy
No statistically signiﬁcant difference was found for any of the lipid or lipoprotein fractions
OO olive oil, NO no oil, FO ﬁsh oil, HDL C high-density lipoprotein cholesterol, LDL C low-density lipoprotein cholesterol, Total C total
cholesterol, TAG triglycerides, Apo apolipoprotein, sdLDL small dense low-density lipoprotein
a Geometric mean, interquartile range in parentheses
b Difference (in %) relative to olive oil, adjusted for sex, 95% conﬁdence interval in parentheses
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